Jinli Wei
- Cancer Research top 10%
- Breast Cancer Treatment Studies 5
- Cancer, Hypoxia, and Metabolism 2
-
- SARS-CoV-2 and COVID-19 Research 2
-
- interferon and immune responses 2
-
- Multiple and Secondary Primary Cancers 3
- Influenza Virus Research Studies 2
-
- Breast Lesions and Carcinomas 2
-
- BRCA gene mutations in cancer 2
- Journals
- Journal for ImmunoTherapy of Cancer (2 papers)Frontiers in Aging Neuroscience (1 paper)Medicine (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Jinli Wei
23 papers receiving 555 citations
Peers
Comparison fields: 5 of 83
- Cancer Research 209
- Infectious Diseases 112
- Oncology 118
- Molecular Biology 269
- Immunology 79
Countries citing papers authored by Jinli Wei
This map shows the geographic impact of Jinli Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinli Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinli Wei more than expected).
Fields of papers citing papers by Jinli Wei
This network shows the impact of papers produced by Jinli Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinli Wei. The network helps show where Jinli Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinli Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 75 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 62 | |
| 6 | 2021 | 41 | |
| 7 | 2021 | 16 | |
| 8 | 2020 | 44 | |
| 9 | 2020 | 12 | |
| 10 | 2019 | 11 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 42 | |
| 13 | 2018 | 74 | |
| 14 | 2018 | 10 | |
| 15 | 2018 | 63 | |
| 16 | 2016 | 5 | |
| 17 | 2015 | 26 | |
| 18 | 2015 | 46 | |
| 19 | 2012 | 2 | |
| 20 | 2008 | 0 |
About Jinli Wei
Jinli Wei is a scholar working on Cancer Research, Biological Psychiatry and Infectious Diseases, having authored 25 papers that have together received 559 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (5 papers), Multiple and Secondary Primary Cancers (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), interferon and immune responses (2 papers), Influenza Virus Research Studies (2 papers), Breast Lesions and Carcinomas (2 papers), BRCA gene mutations in cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (209 citations), Infectious Diseases (112 citations) and Oncology (118 citations). Jinli Wei has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Deyuan Fu, Yi‐Zhou Jiang, Chuanli Ren, Yulin Luo, Zhengquan Zhang, Zhimin Shao, Siyu Wu, Da‐Qiang Li, Jing Li and Yi Xiao. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Frontiers in Aging Neuroscience, Medicine, Frontiers in Immunology and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.